Tech Company Financing Transactions

Melinta Therapeutics Funding Round

Vatera Healthcare Partners, ABS Ventures and Vox Equity Partners participated in a Series B capital raise for Melinta Therapeutics. This venture round was announced on 11/29/2012.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

300 George St. 301
New Haven, CT 06511
USA

Phone

(203) 624-5606

Website

www.melinta.com

Email Address

[email protected]

Overview

Melinta Therapeutics' mission is to discover, develop and commercialize groundbreaking antibiotics to overcome drug-resistant, life-threatening infections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Christine Miller

        

Chief Financial Officer

Peter Milligan

        

VP - Bus. Development

Michael McGuire

        

VP - Finance

Susan Blum

        

VP - General Counsel

Jennifer Sanfilippo

        

Browse more venture capital transactions:

Prev: 11/28/2012: Sopogy venture capital transaction
Next: 11/29/2012: Acquia venture capital transaction

Share this article

About Database of VC Transactions

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary